Drug Discovery

Survey fresh pharmacological responses to cardiovascular disease.

Science News

Cardiovascular Toxicity in Patients Treated for Childhood Cancer
Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health
ICHOM Standard Set for Reporting Outcomes in Heart Valve Disease
Vascular Neurology Considerations for Antiamyloid Immunotherapy
Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science

Journals

Srsf3-Dependent APA Drives Macrophage Maturation and Limits Atherosclerosis
ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism
Daily Heart Rate Per Step (DHRPS): A Wearables Metric Associated with Cardiovascular Disease in a Cross‐Sectional Study of the All of Us Research Program
Effect of Disclosing a Polygenic Risk Score for Coronary Heart Disease on Adverse Cardiovascular Events
DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children’s Oncology Group and the Childhood Cancer Survivor Study

Continuing Education

A speakers asks her audience for a show of hands.
The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.

The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership